Keysight's orders grew 56% on the AI buildout, and its stock still fell 8.7% in a week
Keysight bills at the design and qualification stage, validating AI networks before deployment rather than after, and its fiscal third quarter already showed the wave. The stock still fell 8.7% in the week to October 15 at 47 times earnings, and November 23 decides whether the order cycle outruns the multiple.
Vincent Jiang · 3 min read
Keysight−2.19% — Keysight, down 2.19 percent today Technologies used Open Compute Project week, the open-hardware community's annual summit in San Jose, to launch four validation platforms in three days, machines built to prove the next doubling of AI network speed before anyone deploys it 1267. NVIDIA−0.38% — NVIDIA, down 0.38 percent today, the AI chipmaker, plus Credo−3.11% — Credo, down 3.11 percent today, which sells cables that link AI racks, and Synopsys−4.07% — Synopsys, down 4.07 percent today, a chip-design software and silicon-IP company, put their names on the gear 126. The market's answer landed on October 15, when the shares fell 4.3% to $342.08, an 8.7% drop for the week 4.
The machines that grade the fabric
The centerpiece, AresONE Plus 1600GE, packs eight OSFP1600 ports, a pluggable-module standard carrying 1.6 terabits a second, into a 2U chassis, about nine centimetres of rack height, driving 12.8 terabits of line-rate traffic, which Keysight calls an industry first 17. NVIDIA builds the network gear; Keysight builds the machines that prove the gear works before it ships. Gilad Shainer, NVIDIA's senior vice president of networking, said Spectrum-X AI fabrics get tested on Keysight platforms "before deployment, reducing time to market" 1.

Credo validates its active electrical cables on FITS-16CH, an error tester with 16 channels in each direction, twice the density of the old box 2. Synopsys ran its PCIe 7.0 designs, the rack-scale interconnect that doubles to 128 gigatransfers per second, through Keysight's new protocol tester 6.
The orders already arrived
Fiscal third-quarter revenue, for the period ended July 31, was $1.846 billion, up 36.5% from a year earlier, on filings 89. Orders grew 56% year over year, management said on the August 18 earnings call 5. Earnings of $3.07 a share beat the $2.48 consensus 8. Revenue has risen every quarter since mid-2024, from $1.22 billion to $1.85 billion 9.
Quarterly revenue has climbed every quarter since mid-2024
Data
| Revenue | |
|---|---|
| Q3 '23 | $1.31B |
| Q4 '23 | $1.26B |
| Q1 '24 | $1.22B |
| Q2 '24 | $1.22B |
| Q3 '24 | $1.29B |
| Q4 '24 | $1.3B |
| Q1 '25 | $1.31B |
| Q2 '25 | $1.35B |
| Q3 '25 | $1.42B |
| Q4 '25 | $1.6B |
| Q1 '26 | $1.72B |
| Q2 '26 | $1.85B |
Priced like a winner, sold by insiders
The case for the stock is orders compounding faster than revenue; the case against is a price that already assumes they keep compounding. Keysight trades at 47.1 times trailing earnings against a five-year median of 30.8, after a 68% run this year, and GuruFocus, a stock-analysis site, puts its model's fair value at $225.99, with the shares 51% above it 4. Insiders sold $33.4 million of stock over 12 months and bought none; the same screen still scores the company's financial health 84 out of 100 4.
Also on October 15, Keysight filed the annual UK takeover-code confirmation that it kept the post-offer promises made for Spirent Communications, the London-listed company its cash offer absorbed when the scheme became effective on October 15, 2025 3.
What November 23 decides
Management guided fourth-quarter earnings to $3.34 to $3.40 a share, on a full year near $11.46 8. Results land November 23 5. Watch whether orders keep compounding near 56% year over year, and whether that guidance holds once the fiscal fourth quarter is booked 58. The comparison stops being easy from there: the quarter that ended in January was already growing 23% 9.
Fiscal Q3 beat consensus by 24%, and guidance points higher still
- EPS
- Estimate
Data
| EPS | |
|---|---|
| FQ3 '26 consensus (estimate) | $2.48 |
| FQ3 '26 actual | $3.07 |
| FQ4 '26 guide (estimate) | $3.37 ($3.34–3.40) |
Deepdive
AI-generated from this story and its cited sources. Not investment advice.



